Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 583 entries
Sorted by: Best Match Show Resources per page
Targeting the "Rising DAMP" during a Francisella tularensis Infection.

Antimicrobial agents and chemotherapy

D'Elia RV, Laws TR, Carter A, Lukaszewski R, Clark GC.
PMID: 23796927
Antimicrob Agents Chemother. 2013 Sep;57(9):4222-4228. doi: 10.1128/AAC.01885-12. Epub 2013 Jun 24.

Antibiotic efficacy is greatly enhanced the earlier it is administered following infection with a bacterial pathogen. However, in a clinical setting antibiotic treatment usually commences following the onset of symptoms, which in some cases (e.g., biothreat agents) may be...

Cite
D'Elia RV, Laws TR, Carter A, et al. Targeting the "Rising DAMP" during a Francisella tularensis Infection. Antimicrob Agents Chemother. 2013;57(9):4222-4228doi: 10.1128/AAC.01885-12.
D'Elia, R. V., Laws, T. R., Carter, A., Lukaszewski, R., & Clark, G. C. (2013). Targeting the "Rising DAMP" during a Francisella tularensis Infection. Antimicrobial agents and chemotherapy, 57(9), 4222-4228. https://doi.org/10.1128/AAC.01885-12
D'Elia, Riccardo V, et al. "Targeting the "Rising DAMP" during a Francisella tularensis Infection." Antimicrobial agents and chemotherapy vol. 57,9 (2013): 4222-4228. doi: https://doi.org/10.1128/AAC.01885-12
D'Elia RV, Laws TR, Carter A, Lukaszewski R, Clark GC. Targeting the "Rising DAMP" during a Francisella tularensis Infection. Antimicrob Agents Chemother. 2013 Sep;57(9):4222-4228. doi: 10.1128/AAC.01885-12. Epub 2013 Jun 24. PMID: 23796927; PMCID: PMC3754292.
Copy Download .nbib Format: NLM
Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells.

Antimicrobial agents and chemotherapy

Azad MA, Finnin BA, Poudyal A, Davis K, Li J, Hill PA, Nation RL, Velkov T, Li J.
PMID: 23796937
Antimicrob Agents Chemother. 2013 Sep;57(9):4329-4335. doi: 10.1128/AAC.02587-12. Epub 2013 Jun 24.

The nephrotoxicity of polymyxins is a major dose-limiting factor for treatment of infections caused by multidrug-resistant Gram-negative pathogens. The mechanism(s) of polymyxin-induced nephrotoxicity is not clear. This study aimed to investigate polymyxin B-induced apoptosis in kidney proximal tubular cells....

Cite
Azad MA, Finnin BA, Poudyal A, et al. Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells. Antimicrob Agents Chemother. 2013;57(9):4329-4335doi: 10.1128/AAC.02587-12.
Azad, M. A., Finnin, B. A., Poudyal, A., Davis, K., Li, J., Hill, P. A., Nation, R. L., Velkov, T., & Li, J. (2013). Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells. Antimicrobial agents and chemotherapy, 57(9), 4329-4335. https://doi.org/10.1128/AAC.02587-12
Azad, Mohammad A K, et al. "Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells." Antimicrobial agents and chemotherapy vol. 57,9 (2013): 4329-4335. doi: https://doi.org/10.1128/AAC.02587-12
Azad MA, Finnin BA, Poudyal A, Davis K, Li J, Hill PA, Nation RL, Velkov T, Li J. Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells. Antimicrob Agents Chemother. 2013 Sep;57(9):4329-4335. doi: 10.1128/AAC.02587-12. Epub 2013 Jun 24. PMID: 23796937; PMCID: PMC3754291.
Copy Download .nbib Format: NLM
Erratum for Kim et al., inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus.

Antimicrobial agents and chemotherapy

Kim NH, Koo HL, Choe PG, Cheon S, Kim M, Lee MJ, Jung Y, Park WB, Song KH, Kim ES, Bang JH, Kim HB, Park SW, Kim NJ, Oh MD, Kim EC.
PMID: 25762795
Antimicrob Agents Chemother. 2015 Apr;59(4):2478. doi: 10.1128/AAC.00241-15.

No abstract available.

Cite
Kim NH, Koo HL, Choe PG, et al. Erratum for Kim et al., inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015;59(4):2478doi: 10.1128/AAC.00241-15.
Kim, N. H., Koo, H. L., Choe, P. G., Cheon, S., Kim, M., Lee, M. J., Jung, Y., Park, W. B., Song, K. H., Kim, E. S., Bang, J. H., Kim, H. B., Park, S. W., Kim, N. J., Oh, M. D., & Kim, E. C. (2015). Erratum for Kim et al., inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 59(4), 2478. https://doi.org/10.1128/AAC.00241-15
Kim, Nak-Hyun, et al. "Erratum for Kim et al., inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus." Antimicrobial agents and chemotherapy vol. 59,4 (2015): 2478. doi: https://doi.org/10.1128/AAC.00241-15
Kim NH, Koo HL, Choe PG, Cheon S, Kim M, Lee MJ, Jung Y, Park WB, Song KH, Kim ES, Bang JH, Kim HB, Park SW, Kim NJ, Oh MD, Kim EC. Erratum for Kim et al., inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015 Apr;59(4):2478. doi: 10.1128/AAC.00241-15. PMID: 25762795; PMCID: PMC4356790.
Copy Download .nbib Format: NLM
Erratum for Lee et al., Fast and Accurate Large-Scale Detection of β-Lactamase Genes Conferring Antibiotic Resistance.

Antimicrobial agents and chemotherapy

Lee JJ, Lee JH, Kwon DB, Jeon JH, Park KS, Lee CR, Lee SH.
PMID: 28045668
Antimicrob Agents Chemother. 2016 Oct 21;60(11):7005. doi: 10.1128/AAC.01976-16. Print 2016 Nov.

No abstract available.

Cite
Lee JJ, Lee JH, Kwon DB, et al. Erratum for Lee et al., Fast and Accurate Large-Scale Detection of β-Lactamase Genes Conferring Antibiotic Resistance. Antimicrob Agents Chemother. 2016;60(11):7005doi: 10.1128/AAC.01976-16.
Lee, J. J., Lee, J. H., Kwon, D. B., Jeon, J. H., Park, K. S., Lee, C. R., & Lee, S. H. (2016). Erratum for Lee et al., Fast and Accurate Large-Scale Detection of β-Lactamase Genes Conferring Antibiotic Resistance. Antimicrobial agents and chemotherapy, 60(11), 7005. https://doi.org/10.1128/AAC.01976-16
Lee, Jae Jin, et al. "Erratum for Lee et al., Fast and Accurate Large-Scale Detection of β-Lactamase Genes Conferring Antibiotic Resistance." Antimicrobial agents and chemotherapy vol. 60,11 (2016): 7005. doi: https://doi.org/10.1128/AAC.01976-16
Lee JJ, Lee JH, Kwon DB, Jeon JH, Park KS, Lee CR, Lee SH. Erratum for Lee et al., Fast and Accurate Large-Scale Detection of β-Lactamase Genes Conferring Antibiotic Resistance. Antimicrob Agents Chemother. 2016 Oct 21;60(11):7005. doi: 10.1128/AAC.01976-16. Print 2016 Nov. PMID: 28045668; PMCID: PMC5075135.
Copy Download .nbib Format: NLM
Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection".

Antimicrobial agents and chemotherapy

Micek ST, Hampton N, Kollef M.
PMID: 29475887
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.00007-18. Print 2018 Mar.

No abstract available.

Cite
Micek ST, Hampton N, Kollef M. Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection". Antimicrob Agents Chemother. 2018;62(3)doi: 10.1128/AAC.00007-18.
Micek, S. T., Hampton, N., & Kollef, M. (2018). Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection". Antimicrobial agents and chemotherapy, 62(3), . https://doi.org/10.1128/AAC.00007-18
Micek, Scott T, et al. "Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection"." Antimicrobial agents and chemotherapy vol. 62,3 (2018). doi: https://doi.org/10.1128/AAC.00007-18
Micek ST, Hampton N, Kollef M. Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection". Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.00007-18. Print 2018 Mar. PMID: 29475887; PMCID: PMC5826146.
Copy Download .nbib Format: NLM
Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression.

Antimicrobial agents and chemotherapy

Kamal MA, Gieschke R, Lemenuel-Diot A, Beauchemin CA, Smith PF, Rayner CR.
PMID: 26921415
Antimicrob Agents Chemother. 2016 Feb 26;60(3):1953. doi: 10.1128/AAC.00179-16. Print 2016 Mar.

No abstract available.

Cite
Kamal MA, Gieschke R, Lemenuel-Diot A, et al. Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression. Antimicrob Agents Chemother. 2016;60(3):1953doi: 10.1128/AAC.00179-16.
Kamal, M. A., Gieschke, R., Lemenuel-Diot, A., Beauchemin, C. A., Smith, P. F., & Rayner, C. R. (2016). Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression. Antimicrobial agents and chemotherapy, 60(3), 1953. https://doi.org/10.1128/AAC.00179-16
Kamal, Mohamed A, et al. "Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression." Antimicrobial agents and chemotherapy vol. 60,3 (2016): 1953. doi: https://doi.org/10.1128/AAC.00179-16
Kamal MA, Gieschke R, Lemenuel-Diot A, Beauchemin CA, Smith PF, Rayner CR. Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression. Antimicrob Agents Chemother. 2016 Feb 26;60(3):1953. doi: 10.1128/AAC.00179-16. Print 2016 Mar. PMID: 26921415; PMCID: PMC4775932.
Copy Download .nbib Format: NLM
Antibiotic Resistance in Salmonella enterica Serovar Typhimurium Associates with CRISPR Sequence Type.

Antimicrobial agents and chemotherapy

DiMarzio M, Shariat N, Kariyawasam S, Barrangou R, Dudley EG.
PMID: 23796925
Antimicrob Agents Chemother. 2013 Sep;57(9):4282-4289. doi: 10.1128/AAC.00913-13. Epub 2013 Jun 24.

No abstract available.

Cite
DiMarzio M, Shariat N, Kariyawasam S, et al. Antibiotic Resistance in Salmonella enterica Serovar Typhimurium Associates with CRISPR Sequence Type. Antimicrob Agents Chemother. 2013;57(9):4282-4289doi: 10.1128/AAC.00913-13.
DiMarzio, M., Shariat, N., Kariyawasam, S., Barrangou, R., & Dudley, E. G. (2013). Antibiotic Resistance in Salmonella enterica Serovar Typhimurium Associates with CRISPR Sequence Type. Antimicrobial agents and chemotherapy, 57(9), 4282-4289. https://doi.org/10.1128/AAC.00913-13
DiMarzio, Michael, et al. "Antibiotic Resistance in Salmonella enterica Serovar Typhimurium Associates with CRISPR Sequence Type." Antimicrobial agents and chemotherapy vol. 57,9 (2013): 4282-4289. doi: https://doi.org/10.1128/AAC.00913-13
DiMarzio M, Shariat N, Kariyawasam S, Barrangou R, Dudley EG. Antibiotic Resistance in Salmonella enterica Serovar Typhimurium Associates with CRISPR Sequence Type. Antimicrob Agents Chemother. 2013 Sep;57(9):4282-4289. doi: 10.1128/AAC.00913-13. Epub 2013 Jun 24. PMID: 23796925; PMCID: PMC3754329.
Copy Download .nbib Format: NLM
Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference.

Frontiers in microbiology

Bahadur V, Mastronicola D, Singh AK, Tiwari HK, Pucillo LP, Sarti P, Singh BK, Giuffrè A.
PMID: 25904901
Front Microbiol. 2015 Apr 08;6:256. doi: 10.3389/fmicb.2015.00256. eCollection 2015.

Giardiasis is a common diarrheal disease worldwide caused by the protozoan parasite Giardia intestinalis. It is urgent to develop novel drugs to treat giardiasis, due to increasing clinical resistance to the gold standard drug metronidazole (MTZ). New potential antiparasitic...

Cite
Bahadur V, Mastronicola D, Singh AK, et al. Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference. Front Microbiol. 2015;6:256doi: 10.3389/fmicb.2015.00256.
Bahadur, V., Mastronicola, D., Singh, A. K., Tiwari, H. K., Pucillo, L. P., Sarti, P., Singh, B. K., & Giuffrè, A. (2015). Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference. Frontiers in microbiology, 6256. https://doi.org/10.3389/fmicb.2015.00256
Bahadur, Vijay, et al. "Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference." Frontiers in microbiology vol. 6 (2015): 256. doi: https://doi.org/10.3389/fmicb.2015.00256
Bahadur V, Mastronicola D, Singh AK, Tiwari HK, Pucillo LP, Sarti P, Singh BK, Giuffrè A. Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference. Front Microbiol. 2015 Apr 08;6:256. doi: 10.3389/fmicb.2015.00256. eCollection 2015. PMID: 25904901; PMCID: PMC4389562.
Copy Download .nbib Format: NLM
Experimental Urinary Tract Infection in Rats Caused by Candida albicans.

Antimicrobial agents and chemotherapy

Miraglia GJ, Renz KJ.
PMID: 16557673
Antimicrob Agents Chemother. 1973 Apr;3(4):474-7. doi: 10.1128/AAC.3.4.474.

The increased clinical use of broad-spectrum antibiotics, immunosuppressives, and anti-inflammatory agents is thought to have contributed to the increased incidence of renal infections due to Candida albicans. To aid in the search for improved anticandidal agents, we developed an...

Cite
Miraglia GJ, Renz KJ. Experimental Urinary Tract Infection in Rats Caused by Candida albicans. Antimicrob Agents Chemother. 1973;3(4):474-7doi: 10.1128/AAC.3.4.474.
Miraglia, G. J., & Renz, K. J. (1973). Experimental Urinary Tract Infection in Rats Caused by Candida albicans. Antimicrobial agents and chemotherapy, 3(4), 474-7. https://doi.org/10.1128/AAC.3.4.474
Miraglia, G J, and Renz, K J. "Experimental Urinary Tract Infection in Rats Caused by Candida albicans." Antimicrobial agents and chemotherapy vol. 3,4 (1973): 474-7. doi: https://doi.org/10.1128/AAC.3.4.474
Miraglia GJ, Renz KJ. Experimental Urinary Tract Infection in Rats Caused by Candida albicans. Antimicrob Agents Chemother. 1973 Apr;3(4):474-7. doi: 10.1128/AAC.3.4.474. PMID: 16557673; PMCID: PMC444437.
Copy Download .nbib Format: NLM
Guidelines for reports of clinical studies.

Antimicrobial agents and chemotherapy

Barza M.
PMID: 16557677
Antimicrob Agents Chemother. 1989 Nov;33(11):1829-30. doi: 10.1128/AAC.33.11.1829.

No abstract available.

Cite
Barza M. Guidelines for reports of clinical studies. Antimicrob Agents Chemother. 1989;33(11):1829-30doi: 10.1128/AAC.33.11.1829.
Barza, M. (1989). Guidelines for reports of clinical studies. Antimicrobial agents and chemotherapy, 33(11), 1829-30. https://doi.org/10.1128/AAC.33.11.1829
Barza, M. "Guidelines for reports of clinical studies." Antimicrobial agents and chemotherapy vol. 33,11 (1989): 1829-30. doi: https://doi.org/10.1128/AAC.33.11.1829
Barza M. Guidelines for reports of clinical studies. Antimicrob Agents Chemother. 1989 Nov;33(11):1829-30. doi: 10.1128/AAC.33.11.1829. PMID: 16557677; PMCID: PMC172771.
Copy Download .nbib Format: NLM
Two Structurally Distinct VanA Resistance Elements at Different Locations in a Glycopeptide-Resistant Strain of Enterococcus faecalis.

Antimicrobial agents and chemotherapy

Tremlett CH, Brown DF, Palepou MF, Woodford N.
PMID: 16557681
Antimicrob Agents Chemother. 2001 Mar;45(3):996-7. doi: 10.1128/AAC.45.3.996-997.2001.

No abstract available.

Cite
Tremlett CH, Brown DF, Palepou MF, et al. Two Structurally Distinct VanA Resistance Elements at Different Locations in a Glycopeptide-Resistant Strain of Enterococcus faecalis. Antimicrob Agents Chemother. 2001;45(3):996-7doi: 10.1128/AAC.45.3.996-997.2001.
Tremlett, C. H., Brown, D. F., Palepou, M. F., & Woodford, N. (2001). Two Structurally Distinct VanA Resistance Elements at Different Locations in a Glycopeptide-Resistant Strain of Enterococcus faecalis. Antimicrobial agents and chemotherapy, 45(3), 996-7. https://doi.org/10.1128/AAC.45.3.996-997.2001
Tremlett, C H, et al. "Two Structurally Distinct VanA Resistance Elements at Different Locations in a Glycopeptide-Resistant Strain of Enterococcus faecalis." Antimicrobial agents and chemotherapy vol. 45,3 (2001): 996-7. doi: https://doi.org/10.1128/AAC.45.3.996-997.2001
Tremlett CH, Brown DF, Palepou MF, Woodford N. Two Structurally Distinct VanA Resistance Elements at Different Locations in a Glycopeptide-Resistant Strain of Enterococcus faecalis. Antimicrob Agents Chemother. 2001 Mar;45(3):996-7. doi: 10.1128/AAC.45.3.996-997.2001. PMID: 16557681; PMCID: PMC90415.
Copy Download .nbib Format: NLM
WITHDRAWN: Antimicrobial resistance, class 1 integrons and a novel variant of Genomic Island 1 in Salmonella isolates from Vietnam.

Antimicrobial agents and chemotherapy

Vo AT, van Duijkeren E, Fluit AC, Gaastra W.
PMID: 17403998
Antimicrob Agents Chemother. 2008 Jan 07; doi: 10.1128/AAC.01093-06. Epub 2008 Jan 07.

This manuscript has been withdrawn.

Cite
Vo AT, van Duijkeren E, Fluit AC, et al. WITHDRAWN: Antimicrobial resistance, class 1 integrons and a novel variant of Genomic Island 1 in Salmonella isolates from Vietnam. Antimicrob Agents Chemother. 2008;doi: 10.1128/AAC.01093-06.
Vo, A. T., van Duijkeren, E., Fluit, A. C., & Gaastra, W. (2008). WITHDRAWN: Antimicrobial resistance, class 1 integrons and a novel variant of Genomic Island 1 in Salmonella isolates from Vietnam. Antimicrobial agents and chemotherapy, . https://doi.org/10.1128/AAC.01093-06
Vo, An T T, et al. "WITHDRAWN: Antimicrobial resistance, class 1 integrons and a novel variant of Genomic Island 1 in Salmonella isolates from Vietnam." Antimicrobial agents and chemotherapy vol. (2008). doi: https://doi.org/10.1128/AAC.01093-06
Vo AT, van Duijkeren E, Fluit AC, Gaastra W. WITHDRAWN: Antimicrobial resistance, class 1 integrons and a novel variant of Genomic Island 1 in Salmonella isolates from Vietnam. Antimicrob Agents Chemother. 2008 Jan 07; doi: 10.1128/AAC.01093-06. Epub 2008 Jan 07. PMID: 17403998.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 583 entries